Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
Authors:
- 1 January 2021
- journal article
- letter
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 57 (1) , 106236
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Doxycycline as an Alternative to Azithromycin in Elderly PatientsInternational Journal of Antimicrobial Agents, 2021
- Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluationTravel Medicine and Infectious Disease, 2020
- Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisTravel Medicine and Infectious Disease, 2020
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceTravel Medicine and Infectious Disease, 2020